Literature DB >> 22253334

The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?

Bertram Pitt, Faiez Zannad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22253334     DOI： 10.1161/CIRCIMAGING.111.971143

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  9 in total

1.  Oxidative stress promotes myocardial fibrosis by upregulating KCa3.1 channel expression in AGT-REN double transgenic hypertensive mice.

Authors:  Li-Ping Wang; Su-Jing Fan; Shu-Min Li; Xiao-Jun Wang; Jun-Ling Gao; Xiu-Hong Yang
Journal:  Pflugers Arch       Date:  2017-04-28       Impact factor: 3.657

2.  Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djoussé; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Susan J Zieman; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2014-04-25       Impact factor: 4.897

3.  Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djousse; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Sicovick; Russell P Tracy; Kenneth J Mukamal
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-06-24

4.  The association between cardiovascular risk and cardiovascular magnetic resonance measures of fibrosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Colin J Yi; Colin O Wu; Michael Tee; Chia-Ying Liu; Gustavo J Volpe; Martin R Prince; Gregory W Hundley; Antoinette S Gomes; Rob J van der Geest; Susan Heckbert; João A Lima; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2015-02-12       Impact factor: 5.364

5.  Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative Stress.

Authors:  Olubunmi A Adebiyi; Oluwafeyisetan O Adebiyi; Peter M O Owira
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

6.  Cardiac Fibrosis Is Associated With Decreased Circulating Levels of Full-Length CILP in Heart Failure.

Authors:  Shuin Park; Sara Ranjbarvaziri; Peng Zhao; Reza Ardehali
Journal:  JACC Basic Transl Sci       Date:  2020-04-15

7.  Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.

Authors:  Wei-Ting Chang; Juei-Tang Cheng; Zhih-Cherng Chen
Journal:  Cardiovasc Diabetol       Date:  2016-08-12       Impact factor: 9.951

8.  CMR based measurement of aortic stiffness, epicardial fat, left ventricular myocardial strain and fibrosis in hypertensive patients.

Authors:  Christian Kropidlowski; Michael Meier-Schroers; Daniel Kuetting; Alois Sprinkart; Hans Schild; Daniel Thomas; Rami Homsi
Journal:  Int J Cardiol Heart Vasc       Date:  2020-02-12

Review 9.  The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.

Authors:  Michael Chute; Preetinder Aujla; Sayantan Jana; Zamaneh Kassiri
Journal:  J Cardiovasc Dev Dis       Date:  2019-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.